CERo Therapeutics Holdings, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERO and other ETFs, options, and stocks.

About CERO

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. 

CEO
Christopher B. Ehrlich
CEOChristopher B. Ehrlich
Employees
Employees
Headquarters
Oakland, California
HeadquartersOakland, California
Founded
2021
Founded2021
Employees
Employees

CERO Key Statistics

Market cap
4.07M
Market cap4.07M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
781.62K
Average volume781.62K
High today
$0.535
High today$0.535
Low today
$0.5126
Low today$0.5126
Open price
$0.5171
Open price$0.5171
Volume
248.07K
Volume248.07K
52 Week high
$109.00
52 Week high$109.00
52 Week low
$0.4901
52 Week low$0.4901

People also own

Based on the portfolios of people who own CERO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.